Life Sciences Times, Author at Life Sciences Times

MeMed Reaches 100,000-Patient Milestone for Rapid Infection Diagnostic Test

June 6, 2025

Casma Therapeutics Advances Novel Parkinson’s Drug Candidate Toward Clinical Trials

June 5, 2025

Firefly Health Becomes First National Primary Care Provider to Earn NCQA Virtual Care Accreditation

June 4, 2025

THIS WEEK'S STORIES

enGene Announces Resignation of Chief Medical Officer Dr. Raj Pruthi

June 4, 2025

Geneoscopy’s ColoSense Added to NCCN Guidelines as First-Line Colorectal Cancer Screening Test

June 3, 2025

Allay Therapeutics Secures $57.5M in Series D Funding to Advance Post-Surgical Pain Therapy ATX101

June 5, 2025

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Life Sciences Times

TOP AUTHORS

Most Read

Otsuka’s Sibeprenlimab Shows Strong Results in Phase 3 Trial for IgA Nephropathy

Suffolk Unveils White Paper to Drive Climate Tech Adoption in Construction Industry

Tracer Biotechnologies Partners with QIAGEN to Expand Blood-Based Cancer Testing

MeMed Reaches 100,000-Patient Milestone for Rapid Infection Diagnostic Test

EDITOR PICKS

MeMed Reaches 100,000-Patient Milestone for Rapid Infection Diagnostic Test

Casma Therapeutics Advances Novel Parkinson’s Drug Candidate Toward Clinical Trials

Firefly Health Becomes First National Primary Care Provider to Earn NCQA Virtual Care Accreditation

THIS WEEK'S STORIES

enGene Announces Resignation of Chief Medical Officer Dr. Raj Pruthi

Geneoscopy’s ColoSense Added to NCCN Guidelines as First-Line Colorectal Cancer Screening Test

Allay Therapeutics Secures $57.5M in Series D Funding to Advance Post-Surgical Pain Therapy ATX101

POPULAR CATEGORY

ABOUT US

FOLLOW US